119.94
price down icon1.99%   -2.44
after-market After Hours: 119.94
loading

Biontech Se Adr Stock (BNTX) Latest News

pulisher
Feb 06, 2025

North Texas Took Center Stage at Advanced Therapies Week 2025, Highlighting Innovation and Collaboration in Life Sciences - GlobeNewswire Inc.

Feb 06, 2025
pulisher
Feb 06, 2025

BioNTech SE ADR (BNTX) did well last session? - US Post News

Feb 06, 2025
pulisher
Feb 04, 2025

Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales - Yahoo Finance

Feb 04, 2025
pulisher
Feb 04, 2025

Moderna and BioNTech shares fall after Senate committee vote on RFK Jr. - Investing.com

Feb 04, 2025
pulisher
Feb 04, 2025

Hesai Group ADR (HSAI) shows promising results - US Post News

Feb 04, 2025
pulisher
Feb 03, 2025

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings? - Yahoo Finance

Feb 03, 2025
pulisher
Jan 31, 2025

Validea Benjamin Graham Strategy Daily Upgrade Report1/31/2025 - Nasdaq

Jan 31, 2025
pulisher
Jan 29, 2025

BioNTech's SWOT analysis: oncology pipeline, cash boost stock outlook - Investing.com

Jan 29, 2025
pulisher
Jan 27, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jan 27, 2025
pulisher
Jan 22, 2025

Stocks To Watch: BioNTech ADR Sees Relative Strength Rating Rise To 84 - Inkl

Jan 22, 2025
pulisher
Jan 21, 2025

Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know - MSN

Jan 21, 2025
pulisher
Jan 17, 2025

Years-Old List of Alleged Pfizer COVID-19 Vaccine 'Side Effects' Is Misleading - Snopes.com

Jan 17, 2025
pulisher
Jan 14, 2025

BioNTech Expands Cancer Drug Pipeline: Launches Key Lung Cancer Trials, Advances Immunotherapy Programs - StockTitan

Jan 14, 2025
pulisher
Jan 13, 2025

Why BioNTech (BNTX) Shares Are Volatile TodayBioNTech (NASDAQ:BNTX) - Benzinga

Jan 13, 2025
pulisher
Jan 08, 2025

BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch

Jan 08, 2025
pulisher
Jan 08, 2025

What’s Behind The Recent Rise In MRNA Stock? - Forbes

Jan 08, 2025
pulisher
Jan 07, 2025

BioNTech SE ADR rises Tuesday, outperforms market - MarketWatch

Jan 07, 2025
pulisher
Jan 07, 2025

Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike - Investor's Business Daily

Jan 07, 2025
pulisher
Jan 06, 2025

BioNTech SE ADR rises Monday, outperforms market - MarketWatch

Jan 06, 2025
pulisher
Jan 06, 2025

BNTX: 3 Genomic Stocks Unlocking the Secrets of DNA - StockNews.com

Jan 06, 2025
pulisher
Jan 03, 2025

BioNTech SE ADR rises Friday, still underperforms market - MarketWatch

Jan 03, 2025
pulisher
Jan 02, 2025

BioNTech SE ADR rises Thursday, outperforms market - MarketWatch

Jan 02, 2025
pulisher
Jan 02, 2025

Russia develops mRNA cancer vaccine for citizens, skepticism lingers - Mugglehead

Jan 02, 2025
pulisher
Dec 30, 2024

BioNTech SE ADR falls Monday, underperforms market - MarketWatch

Dec 30, 2024
pulisher
Dec 27, 2024

BioNTech SE ADR rises Friday, outperforms market - MarketWatch

Dec 27, 2024
pulisher
Dec 26, 2024

BioNTech SE ADR falls Thursday, underperforms market - MarketWatch

Dec 26, 2024
pulisher
Dec 24, 2024

BioNTech SE ADR rises Tuesday, still underperforms market - MarketWatch

Dec 24, 2024
pulisher
Dec 23, 2024

BioNTech SE ADR rises Monday, still underperforms market - MarketWatch

Dec 23, 2024
pulisher
Dec 18, 2024

Stocks Generating Improved Relative Strength: BioNTech ADR - Investor's Business Daily

Dec 18, 2024
pulisher
Dec 16, 2024

BioNTech's SWOT analysis: mRNA pioneer's stock faces oncology pipeline test - Investing.com

Dec 16, 2024
pulisher
Dec 13, 2024

BioNTech SE ADR falls Friday, underperforms market - MarketWatch

Dec 13, 2024
pulisher
Dec 11, 2024

BioNTech SE ADR rises Wednesday, outperforms market - MarketWatch

Dec 11, 2024
pulisher
Dec 10, 2024

BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch

Dec 10, 2024
pulisher
Dec 03, 2024

BioNTech's SWOT analysis: mRNA pioneer's stock balances COVID legacy, oncology future - Investing.com

Dec 03, 2024
pulisher
Nov 25, 2024

Stocks Showing Improving Market Leadership: BioNTech ADR Earns 81 RS Rating - Investor's Business Daily

Nov 25, 2024
pulisher
Nov 22, 2024

BioNTech ADR Earns Relative Strength Rating Upgrade - Investor's Business Daily

Nov 22, 2024
pulisher
Nov 21, 2024

BioNTech's SWOT analysis: oncology pipeline fuels stock's potential amid market volatility - Investing.com

Nov 21, 2024
biotechnology ONC
$228.87
price up icon 0.53%
$278.25
price up icon 0.70%
$5.04
price down icon 2.14%
$657.97
price down icon 2.05%
$353.75
price down icon 0.12%
Cap:     |  Volume (24h):